Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together ...

MONROVIA, CA / ACCESS Newswire / June 26, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, ...

MESA, AZ / ACCESS Newswire / June 26, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) proudly announces that its subsidiary, Real Game Used, is experiencing growth and industry momentum as ...

EnableComp, XTend Healthcare, Cedar, Knowtion Health, and others recognized as top performers in ten distinct AR categories, as health systems and providers acknowledge that complex AR recovery is not ...

SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ...

AGM/EGM/DividendDermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share 26.06.2025 / 17:43 CET/CESTThe issuer is solely responsible for the content of this ...

ATLANTA, GEORGIA / ACCESS Newswire / June 26, 2025 / Why do my feet peel in the summer? If you've asked yourself this question, you're not alone. Many people notice peeling skin on their feet during ...

Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ...

New Edition Offers Actionable Insights for MedTech Companies and More Targeting Hospital Infrastructure Growth in the Region MIAMI, FL / ACCESS Newswire / June 26, 2025 / As Latin America's healthcare ...

Webcast and conference call to be held on Monday, June 30th at 4:30 pm ET, dial in information below NEWARK, CA / ACCESS Newswire / June 26, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that ...

SynaptixBio, the only company licensed to commercialise a treatment for a rare but deadly disease, welcomes the announcement but says it lacks a detailed plan The government has announced that every ...